Chan-il Chang

Chan Il Chang joined Atinum Investment in 2016 and is investing in bio-healthcare sector.
He focuses on investing in new bio-technology with high growth potential and helps growth of portfolio companies through continuous consulting on the overall development of new drugs, such as pipeline development and clinical strategies from the initial stage of research.
Prior to joining Atinum Investment, he worked at Harvard Medical School and Olix for research and development.
He received an undergraduate degree and a doctorate from Pohang University of Science & Technology.